logo
#

Latest news with #Hib

Boy, 8, complains of headache at school then events turn tragic in hours
Boy, 8, complains of headache at school then events turn tragic in hours

Daily Mirror

time4 days ago

  • Health
  • Daily Mirror

Boy, 8, complains of headache at school then events turn tragic in hours

Ashlee Dahlberg, from Indiana, US, says she felt her son Liam's 'heart fade away' after he suddenly contracted a bacterial infection. She shared the warning signs of the deadly illness A young boy who suffered a headache at school tragically died of a horror infection just hours after complaining about the symptom. Liam Dahlberg, 8, from Indiana, US, came home from class in April and felt unwell. But it wasn't until the following morning that his mum became concerned. ‌ His mother, Ashlee Dahlberg, raced him to hospital where she was told that "there's just nothing we could do", after delivering her a devastating diagnosis. Liam had picked up a bacterial infection called Haemophilus influenzae type b, also known as 'H. flu' or 'Hib.' ‌ Most children are vaccinated against the deadly illness as a baby, but it is still possible to become infected by it, warned doctors. His mother spoke to local media and said: 'Anybody that contracts it usually dies within 24 hours." ‌ Shocking test results from an MRI revealed that the infection had worsened, spreading to his brain and spinal cord. "Basically, at that point in time, there was nothing they could do,' his mum said. According to the Cleveland Clinic, the infection can travel through respiratory droplets and can stay dormant in healthy people, reports New York Post. However, anyone who experiences a low immune system, could see the infection enter the bloodstream - which later can spread to vital organs. Dr. Eric Yancy, a paediatrician in Indianapolis, stressed how quickly Hib can harm patients. 'If it didn't kill the children within a very short period of time, it left many of them with significant complications,' he told 13WMAZ. Despite Liam being vaccinated against the infection, he could have contracted it from someone who wasn't protected. The poor eight-year-old died less than 24 hours after enduring a headache. His mother revealed how she felt his "little heartbeat fade away" before his death. She added: "I would never wish this kind of pain on my worst enemy ever. It's hard. 'To have sat there and listened to the doctors say, 'You did everything right, there's just nothing we could do,' to lay there with him as they took him off life support, I can feel his little heartbeat fade away — there's no words that can describe that pain.'

Indiana boy, 8, dies within hours of catching rare infection that spread to his brain and spine
Indiana boy, 8, dies within hours of catching rare infection that spread to his brain and spine

New York Post

time5 days ago

  • Health
  • New York Post

Indiana boy, 8, dies within hours of catching rare infection that spread to his brain and spine

An Indiana boy died hours after he complained of only mild symptoms that ended up being a rare and fatal bacterial infection, his grieving mother revealed. Liam Dahlberg, 8, came home from school complaining of a headache in April, but it wasn't until the following morning that his mom, Ashlee Dahlberg, realized something was wrong with her usually lively and upbeat son, she told 13WMAZ. She rushed Liam to the hospital, where doctors diagnosed him with the extremely deadly Haemophilus influenzae type b, also known as 'H. flu' or 'Hib.' 4 Liam Dahlberg, 8, died hours after he complained of only mild symptoms that ended up being a rare and fatal bacterial infection. GoFundMe Hib is a bacterial infection — not a virus — that most children are vaccinated against as babies, but even so, it's still possible to contract it, especially at younger and much older ages. 'Anybody that contracts it usually dies within 24 hours,' the heartbroken mother said. An MRI showed that the infection had spread and was covering the 8-year-old's brain and spinal cord. 'Basically, at that point in time, there was nothing they could do,' Dahlberg revealed. Liam died less than 24 hours after complaining of a headache. 'I would never wish this kind of pain on my worst enemy ever. It's hard,' Dahlberg cried as she painstakingly spoke about losing her son in the blink of an eye. 4 Doctors diagnosed Liam with the extremely deadly Haemophilus influenzae type b, also known as 'H. flu' or 'Hib.' 'To have sat there and listened to the doctors say, 'You did everything right, there's just nothing we could do,' to lay there with him as they took him off life support, I can feel his little heartbeat fade away — there's no words that can describe that pain.' Hib infections can be 'invasive,' or rather spread to parts of the body that are typically free from germs, according to the Cleveland Clinic. The infection is usually spread through respiratory droplets and can remain dormant in the noses and throats of healthy people. However, a weakened immune system or individuals already suffering from viral infections can allow Hib to enter the bloodstream, giving the bacteria a pathway to spread to the host's organs. 4 An MRI showed that the infection had spread and was covering the 8-year-old's brain and spinal cord. GoFundMe Dr. Eric Yancy, a pediatrician in Indianapolis familiar with the deadly bacterial infection, told 13WMAZ that up until vaccines for Hib were introduced in 1985, it was 'absolutely devastating.' 'If it didn't kill the children within a very short period of time, it left many of them with significant complications,' Yancy shared. Dahlberg said Liam was vaccinated against Hib, but Yancy explained that her son likely contracted it from a child who was unvaccinated against the bacterial infection — meaning more children could be at risk of exposure. 4 Liam died less than 24 hours after complaining of a headache. GoFundMe Before the vaccine was introduced for children and then for infants in 1990, 'about 20,000 children younger than 5 had a severe Hib disease each year, and about 1,000 died,' according to the Cleveland Clinic. Since then, Hib infection rates have dramatically dropped in the US by more than 99% since 1991. By 2019, 0.15 out of every 100,000 children younger than 5 years old had a Hib disease. In 2024, fewer than 50 cases were reported in the US, according to the CDC. However, Dahlberg is urging parents to ensure their children are vaccinated against Hib so that other families never have to experience the same loss. 'I feel like I have failed my child because I could not protect him from everything that would cause harm,' the grieving mother said.

Boy, 8, Contracts Rare Bacterial Illness, Dies 16 Hours Later: ‘I Could Feel His Little Heartbeat Fade Away'
Boy, 8, Contracts Rare Bacterial Illness, Dies 16 Hours Later: ‘I Could Feel His Little Heartbeat Fade Away'

Yahoo

time5 days ago

  • General
  • Yahoo

Boy, 8, Contracts Rare Bacterial Illness, Dies 16 Hours Later: ‘I Could Feel His Little Heartbeat Fade Away'

Ashlee Dahlberg's son, Liam, came home from school with a headache; the next day he was rushed to the hospital, nearly unresponsive An MRI that showed the 8-year-old's brain and spinal cord were covered by invasive Haemophilus influenzae bacteria, a sign of untreatable meningitis Dahlberg is urging others to vaccinate their children against Hib, as doctors say Liam likely caught it from an unvaccinated childAn 8-year-old Indiana boy died of a rare bacterial infection after he likely caught it from an unvaccinated child, according to doctors. 'This is not your typical everyday flu,' Ashlee Dahlberg said in an interview with WHTR, where she shared how invasive Haemophilus influenzae, also known as "H. flu,' or 'Hib' killed her son within hours. Liam Dahlberg came home from school in April with a headache. The next morning, the family rushed the barely responsive child to the hospital. An MRI revealed the unthinkable: 'They discovered the amount of bacteria that was covering his brain and his spinal cord,' his mother told the outlet. 'At that point in time, that's when there was there was nothing they could do.' Haemophilus influenzae causes a type of bacterial infection, the Cleveland Clinic explains, that despite its name, is unrelated to the flu. A mild infection causes bronchitis; more severe outcomes include septic arthritis, septicemia — and as was the case with Liam, meningitis (infection in the brain and spinal cord). She shared a video of her son writhing in pain and moaning in the hospital, telling the outlet, 'I would never wish this kind of pain on my worst enemy ever. To have sat there and listened to the doctor say you did everything right, but there was just nothing we could do, and then to lay there with him as they took him off life support. And I could feel his little heartbeat just fade away.' Pediatrician Dr. Eric Yancy told WHTR that the disease was 'absolutely devastating' before the vaccine was available. He said it was likely Liam caught Hib from someone unvaccinated — possibly a child, as vaccination rates have fallen. As the Children's Hospital of Pennsylanvia (CHOP) explains, before the Hib vaccine was introduced in 1985, about 20,000 children in the United States would develop serious, sometimes fatal infections. 'Most children harmed by Hib were previously healthy and well nourished,' CHOP says, adding that children who recover from a Hib infection may be left paralyzed, deaf, blind, or mentally impaired. It's spread through respiratory droplets, the Cleveland Clinic explains, and can be contagious even if the person infected doesn't exhibit symptoms. 'Liam was a bright and smart young boy, full of life and potential. His presence brought joy and warmth to everyone he met,' his family wrote in a GoFundMe established to help pay their unexpected medical costs. 'There's no words that can describe that pain,' Dahlberg told WHTR. 'I feel I have failed my child because I could not protect him from everything that would cause harm.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Read the original article on People

8-year-old boy contracts H flu and dies within 20 hours. ‘Nothing they could do'
8-year-old boy contracts H flu and dies within 20 hours. ‘Nothing they could do'

Miami Herald

time5 days ago

  • Health
  • Miami Herald

8-year-old boy contracts H flu and dies within 20 hours. ‘Nothing they could do'

An 8-year-old boy contracted a bacterial infection from a classmate and died within 20 hours, his Indiana mom said. Ashlee Dahlberg, of Lowell, is now imploring parents to vaccinate their children following the April 28 death of her son, Liam Dahlberg. She told WTHR her immunocompromised son complained about a headache when he returned home from school. When he was taken to a hospital the next morning, an MRI uncovered 'bacteria that was covering his brain and spinal cord,' the mother said. 'At that point in time, there was nothing they could do,' Dahlberg told WTHR. Liam had contracted H flu, also known as Haemophilus influenzae or Hib. The disease developed into a meningitis infection, a loved one said in a GoFundMe. Liam, described in the GoFundMe as a 'bright and smart young boy... full of life and potential,' was declared brain dead within 20 hours following the onset of his symptoms, his mother said in a Facebook post. 'To sit there and be told my son was a 1 in a million case and that he was basically handed his death card the minute he came into contact with that UNVACCINATED child, who is a carrier because of the simple fact he/she is UNVACCINATED, makes me sick,' Dahlberg said. Haemophilus influenzae bacteria live in people's noses and throat, and while they don't typically cause harm, they can travel across the body and pose danger, according to the U.S. Centers for Disease Control and Prevention. The bacteria is spread to others when people breathe in small respiratory droplets that are created when an infected person coughs or sneezes, the CDC says. Health officials say the best way to prevent H flu is to get vaccinated, as the CDC recommends all children younger than 5 to receive a vaccination for the disease. It's why Dahlberg has created a petition asking for religious exemptions for school immunizations to be eliminated. 'We must act swiftly and decisively to prevent further tragedies,' she said in the petition. 'Ensuring that all children in public schools are vaccinated, barring medical exemptions, protects not only those children but all members of society.' Liam was a third grade student at Lake Praire Elementary School in Lowell, according to an obituary. Lowell is about a 135-mile drive northwest from Indianapolis.

Acthib, Omnihib Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029F, 2034F
Acthib, Omnihib Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029F, 2034F

Yahoo

time15-05-2025

  • Business
  • Yahoo

Acthib, Omnihib Market Research Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029F, 2034F

The key company operating in the acthib, omnihib market is Sanofi SA. North America was the largest region in the acthib, omnihib market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acthib, omnihib report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the acthib, omnihib market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Acthib, Omnihib Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to Acthib, Omnihib market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market. ActHIB and OmniHIB are vaccines designed to protect against invasive diseases caused by Haemophilus influenzae type b (Hib), including conditions such as meningitis and pneumonia. ActHIB is a conjugate vaccine, which combines the Hib capsular polysaccharide with a protein, while OmniHIB is a similar conjugate vaccine. Both vaccines are primarily given to infants and children to help build immunity. They play a vital role in preventing Hib-related illnesses, which can be severe or acthib, omnihib market consists of sales of Hib vaccines, boosters, and pediatric vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the growth during the historical period can be attributed to the expansion of global immunization programs, increased pediatric vaccination rates, a surge in Hib disease outbreaks, higher adoption of combination vaccines, and growing public awareness of vaccine-preventable diseases. Market growth during the forecast period is driven by increasing awareness and efforts to control Hib infections, a rise in the incidence of Hib-related infections, expanding immunization rates, greater use of antibiotics and glucocorticoids, and the rising prevalence of chronic diseases. Key trends during the forecast period include advancements in pediatric vaccination, improvements in vaccine technology, innovation and new product developments, and progress in vaccine delivery growing prevalence of Haemophilus influenzae type b (Hib) infections is expected to drive the growth of the ActHIB and OmniHIB market. Haemophilus influenzae type b infections are serious bacterial infections caused by the Haemophilus influenzae type b bacteria, which can lead to conditions such as meningitis, pneumonia, and epiglottitis, primarily affecting young children. The rise in Hib infections can be attributed to factors such as declining vaccination rates, the emergence of antibiotic resistance, and limited access to healthcare in certain regions. ActHIB and OmniHIB vaccines are designed to protect against Hib infections by stimulating the immune system to recognize and combat the bacteria. For example, a report from the European Centre for Disease Prevention and Control (ECDC) in July 2024 noted a significant increase in confirmed cases of invasive Haemophilus influenzae disease, with 3,967 cases reported in 2022, a sharp rise from 1,694 cases in 2021. This increasing prevalence of Hib infections is driving the demand for ActHIB and OmniHIB rise in healthcare expenditure is expected to support the growth of the ActHIB and OmniHIB market. Healthcare expenditure refers to the total spending on healthcare services, including personal care, preventive services, and public health activities aimed at improving health outcomes. This expenditure is increasing due to factors such as an aging population, rising chronic diseases, advanced medical technology, high drug costs, and inefficiencies in payment models, along with a growing demand for healthcare services. As healthcare spending increases, it can enhance the accessibility and affordability of vaccines such as ActHIB and OmniHIB, thereby influencing vaccination rates and public health outcomes. For instance, in May 2024, the Office for National Statistics in the UK reported a 5.6% rise in total healthcare expenditure from 2022 to 2023, compared to a growth rate of just 0.9% the previous year. Additionally, long-term health and social care expenditure grew by 2.8% in real terms in 2022. As a result, rising healthcare expenditure is contributing to the growth of the ActHIB and OmniHIB in biopharmaceutical solutions are another key factor driving growth in the ActHIB and OmniHIB market. A significant trend is the development of innovative combination vaccines that provide broader protection against multiple diseases while reducing the number of shots needed for immunization. A conjugate vaccine, which combines a bacterial polysaccharide with a protein to boost the immune response, is an example of such an Topics Covered: 1. Executive Summary2. Acthib, Omnihib Market Characteristics3. Acthib, Omnihib Market Biologic Drug Characteristics3.1. Molecule Type3.2. Route of Administration (ROA)3.3. Mechanism of Action (MOA)3.4. Safety and Efficacy4. Acthib, Omnihib Market Trends and Strategies5. Acthib, Omnihib Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market6. Global Acthib, Omnihib Growth Analysis and Strategic Analysis Framework6.1. Global Acthib, Omnihib PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)6.2. Analysis of End Use Industries6.3. Global Acthib, Omnihib Market Growth Rate Analysis6.4. Global Acthib, Omnihib Historic Market Size and Growth, 2019-2024, Value ($ Million)6.5. Global Acthib, Omnihib Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Million)6.6. Global Acthib, Omnihib Total Addressable Market (TAM)7. Global Acthib, Omnihib Pricing Analysis & Forecasts8. Acthib, Omnihib Market Segmentation8.1. Global Acthib, Omnihib Market, Segmentation by Type of Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million Monovalent Hib Vaccines Combination Vaccines 8.2. Global Acthib, Omnihib Market, Segmentation by Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million Haemophilus Influenzae Type B (HIB) Infection 8.3. Global Acthib, Omnihib Market, Segmentation by Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million Infants and Toddlers Adults 8.4. Global Acthib, Omnihib Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million Hospitals and Clinics Retail Pharmacies 9. Global Acthib, Omnihib Epidemiology of Clinical Indications9.1. Drug Side Effects9.2. Incidence and Prevalence of Clinical Indications10. Acthib, Omnihib Market Regional and Country Analysis10.1. Global Acthib, Omnihib Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million10.2. Global Acthib, Omnihib Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store